Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration
暂无分享,去创建一个
D. Fleisher | L. Pao | A. Karim | C Li | D Fleisher | L H Pao | Y Zhou | A Karim | Cheng Li | Yuji Zhou
[1] S. Lewis,et al. Intestinal absorption of oestrogen: the effect of altering transit‐time , 1998, European journal of gastroenterology & hepatology.
[2] C. Marchbanks. Drug‐Drug Interactions With Fluoroquinolones , 1993, Pharmacotherapy.
[3] L. Benet,et al. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[4] C. Lieber. Mechanisms of ethanol-drug-nutrition interactions. , 1994, Journal of toxicology. Clinical toxicology.
[5] Lawrence X. Yu,et al. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans , 1996 .
[6] D. Sadowski. Drug Interactions with Antacids , 1994, Drug safety.
[7] W. Heizer,et al. Effect of Altering Small Bowel Transit Time on Sustained Release Theophylline Absorption , 1989, Journal of clinical pharmacology.
[8] O. H. Chan,et al. Discrimination between drug candidates using models for evaluation of intestinal absorption , 1997 .
[9] J. Mucklow,et al. Studies of the oral bioavailability of alendronate , 1995, Clinical pharmacology and therapeutics.
[10] C. Lieber,et al. Inhibition of drug metabolism by acute ethanol intoxication. A hepatic microsomal mechanism. , 1970, The American journal of medicine.
[11] P. du Souich,et al. Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules. , 1990, Biopharmaceutics & drug disposition.
[12] J. Lin,et al. pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[13] K. Ogawa,et al. Gastrointestinal absorption of chlorothiazide: evaluation of a method using salicylazosulfapyridine and acetaminophen as the marker compounds for determination of the gastrointestinal transit time in the dog. , 1990, Chemical & pharmaceutical bulletin.
[14] G. Garber,et al. The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patients. , 1992, British journal of clinical pharmacology.
[15] N. Mizuno,et al. Effect of a high-fat meal on the bioavailability of phenytoin in a commercial powder with a large particle size. , 1993, International journal of clinical pharmacology, therapy, and toxicology.
[16] J. R. Green,et al. Pharmacokinetics of carbamazepine in normal man , 1975, Clinical pharmacology and therapeutics.
[17] H. Liedholm,et al. Concomitant food intake does enhance the bioavailability and effect of hydralazine , 1985, Clinical pharmacology and therapeutics.
[18] W. Barron,et al. Effect of food on the absorption of frusemide and bumetanide in man. , 2003, British journal of clinical pharmacology.
[19] U. Fuhr. Drug Interactions with Grapefruit Juice , 1998, Drug safety.
[20] H. Schröder,et al. Absorption, metabolism, and excretion of salicylazosulfapyridine in man , 1972, Clinical pharmacology and therapeutics.
[21] A. Mclean,et al. Reduction of first‐pass hepatic clearance of propranolol by food , 1981, Clinical pharmacology and therapeutics.
[22] P. McNamara,et al. Food, splanchnic blood flow, and bioavailability of drugs subject to first‐pass metabolism , 1978, Clinical pharmacology and therapeutics.
[23] R. Helmreich,et al. The importance of human factors in the operating room. , 1994, Anesthesiology.
[24] J. Tillement,et al. Systemic Antifungal Agents , 1998, Drug safety.
[25] T. Schiano,et al. Decreased intrinsic factor secretion in AIDS: relation to parietal cell acid secretory capacity and vitamin B12 malabsorption. , 1992, The American journal of gastroenterology.
[26] R. Juhl,et al. Decreased bioavailability of digoxin due to antacids and kaolin-pectin. , 1976, The New England journal of medicine.
[27] J. Wagner,et al. Influence of kaolin--pectin suspension on digoxin bioavailability. , 1978, Journal of pharmaceutical sciences.
[28] H. Pan,et al. Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia , 1990, Clinical pharmacology and therapeutics.
[29] D. Bagchi,et al. Stress, diet and alcohol‐induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth subsalicylate , 1998, Journal of applied toxicology : JAT.
[30] S. Mochizuki,et al. Influence of cisapride on the pharmacokinetics and antihypertensive effect of sustained-release nifedipine. , 1996, Internal medicine.
[31] H. Liedholm,et al. Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation , 1986, Clinical pharmacology and therapeutics.
[32] Sievers Ml. A study of achlorhydria among southwestern American Indians. , 1966 .
[33] P. Gubbins,et al. Drug Absorption in Gastrointestinal Disease and Surgery , 1991, Clinical pharmacokinetics.
[34] H. Gin,et al. The Influence of Guar Gum on Absorption of Metformin from the Gut in Healthy Volunteers , 1989, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[35] K. Desante,et al. Pharmacokinetic evaluation of a drug interaction between kaolin--pectin and clindamycin. , 1978, Journal of pharmaceutical sciences.
[36] M. Kamm,et al. The effect of an antacid and food on the absorption of cimetidine and ranitidine , 1990, The Journal of pharmacy and pharmacology.
[37] H. Lode,et al. Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid , 1989, Antimicrobial Agents and Chemotherapy.
[38] C. le Grimellec,et al. Increase in membrane fluidity modulates sodium-coupled uptakes and cyclic AMP synthesis by renal proximal tubular cells in primary culture. , 1990, Biochimica et biophysica acta.
[39] K. Lawson,et al. Olestra, a nonabsorbed, noncaloric replacement for dietary fat: a review. , 1997, Drug metabolism reviews.
[40] J. Kisicki,et al. Effect of Increasing Gastric pH with Famotidine on the Absorption and Oral Pharmacokinetics of the Inotropic Agent Vesnarinone , 1998, Journal of clinical pharmacology.
[41] S. Bondesen,et al. Kinetics of 5-aminosalicylic acid after jejunal instillation in man. , 1983, British journal of clinical pharmacology.
[42] D. Fleisher,et al. Influence of D-glucose-induced water absorption on rat jejunal uptake of two passively absorbed drugs. , 1992, Journal of pharmaceutical sciences.
[43] J. Dressman,et al. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. , 1997, Journal of pharmaceutical sciences.
[44] O. Keene,et al. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. , 1991, European neurology.
[45] C. Regårdh,et al. Effects of grapefruit juice ingestion – pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men , 1997, European Journal of Clinical Pharmacology.
[46] J. Meyer,et al. Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient. , 1989, The American journal of physiology.
[47] G. Lensmeyer,et al. Effect of a high-protein meal on gabapentin pharmacokinetics , 1996, Epilepsy Research.
[48] D. B. Goldstein,et al. The effects of drugs on membrane fluidity. , 1984, Annual review of pharmacology and toxicology.
[49] J. Elashoff,et al. Gastric emptying of solid food is most potently inhibited by carbohydrate in the canine distal ileum. , 1992, Gastroenterology.
[50] A. Pearson,et al. Intestinal permeability in Crohn's disease. , 1989, Archives of disease in childhood.
[51] A. Zinsmeister,et al. Relation between antral motility and gastric emptying of solids and liquids in humans. , 1985, The American journal of physiology.
[52] E. Brendel,et al. Carvedilol increases the systemic bioavailability of oral digoxin. , 1990, British journal of clinical pharmacology.
[53] L Hendeles,et al. Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity. , 1985, Chest.
[54] G. Amidon,et al. Oral absorption of 21-corticosteroid esters: a function of aqueous stability and intestinal enzyme activity and distribution. , 1986, Journal of pharmaceutical sciences.
[55] P. Gubbins,et al. Drug Absorption in Gastrointestinal Disease and Surgery , 1989, Pharmacotherapy.
[56] K. Brouwer,et al. Physiologic pharmacokinetic modeling of gastrointestinal blood flow as a rate-limiting step in the oral absorption of digoxin: implications for patients with congestive heart failure receiving epoprostenol. , 1996, Journal of pharmaceutical sciences.
[57] M. Fischl,et al. Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections , 1996, Antimicrobial agents and chemotherapy.
[58] P. Schwandt,et al. Interaction between fibre and Iovastatin , 1991, The Lancet.
[59] P. Welling. Interactions Affecting Drug Absorption , 1984, Clinical pharmacokinetics.
[60] L. Munck,et al. Baclofen (β-p-chlorophenyl-γ-aminobutyric acid) transport across rat jejunum , 1993 .
[61] V. Shah,et al. Influence of dioctyl sodium sulfosuccinate on the absorption of tetracycline. , 1986, Biopharmaceutics & drug disposition.
[62] J. Morley,et al. Do calories, osmolality, or calcium determine gastric emptying? , 1985, The American journal of physiology.
[63] L. Benet,et al. Effect of Food on the Pharmacokinetics of Cyclosporine in Healthy Subjects Following Oral and Intravenous Administration , 1990, Journal of clinical pharmacology.
[64] U. Fuhr,et al. Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule. , 1990, British journal of clinical pharmacology.
[65] J. A. Thomas,et al. Interactions between drugs and nutrients. , 1996, Advances in pharmacology.
[66] Peter B. Goldman. Olestra: Assessing its potential to interact with drugs in the gastrointestinal tract , 1997, Clinical pharmacology and therapeutics.
[67] P. Welling,et al. Influence of food and fluid volume on chlorothiazide bioavailability: comparison of plasma and urinary excretion methods. , 1982, Journal of pharmaceutical sciences.
[68] P. Sinko,et al. Carrier‐mediated intestinal absorption of valacyclovir, the L‐valyl ester prodrug of acyclovir. 1. Interactions with peptides, organic anions and organic cations in rats , 1998, Biopharmaceutics & drug disposition.
[69] G. Amidon,et al. Noncompetitive inhibition of cephradine uptake by enalapril in rabbit intestinal brush-border membrane vesicles: an enalapril specific inhibitory binding site on the peptide carrier. , 1994, The Journal of pharmacology and experimental therapeutics.
[70] J. Kuhlmann,et al. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin. , 1997, International journal of clinical pharmacology and therapeutics.
[71] S. Broder,et al. Pharmacokinetics of 2',3' ‐dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medications , 1991, Clinical pharmacology and therapeutics.
[72] J. Zhi,et al. The Effect of Orlistat, an Inhibitor of Dietary Fat Absorption, on the Pharmacokinetics of β‐Carotene in Healthy Volunteers , 1996, Journal of clinical pharmacology.
[73] F. Merkus,et al. New insights into the pharmacokinetics of spironolactone , 1985, Clinical pharmacology and therapeutics.
[74] G. Amidon,et al. Peptide-based Drug Design, Controlling Transport and Metabolism , 1995 .
[75] A. Li,et al. Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction. , 1997, Chemico-biological interactions.
[76] P. Tothill,et al. EFFECT OF GEL FIBRE ON GASTRIC EMPTYING AND ABSORPTION OF GLUCOSE AND PARACETAMOL , 1979, The Lancet.
[77] D. Rowbotham,et al. Pharmacokinetic Drug Interactions with Gastrointestinal Motility Modifying Agents , 1994, Clinical pharmacokinetics.
[78] R. Jandacek. The effect of nonabsorbable lipids on the intestinal absorption of lipophiles. , 1982, Drug metabolism reviews.
[79] R. Unger,et al. Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients. , 1979, Endocrinology.
[80] T. Chaudhuri,et al. Update: pharmaceuticals and gastric emptying. , 1990, The American journal of gastroenterology.
[81] D. Giesing,et al. Effect of food coadministration on 5‐aminosalicylic acid oral suspension bioavailability , 1990, Clinical pharmacology and therapeutics.
[82] T. Gramatté,et al. Paracetamol absorption from different sites in the human small intestine. , 1994, British journal of clinical pharmacology.
[83] R. Nayak,et al. Effects of Meals and Meal Composition on the Bioavailability of Fenretinide , 1992, Journal of clinical pharmacology.
[84] J. Sotelo,et al. Pharmacokinetic study of praziquantel administered alone and in combination with cimetidine in a single-day therapeutic regimen , 1997, Antimicrobial agents and chemotherapy.
[85] D. Fleisher,et al. Nutrient effects on intestinal drug absorption. , 1990 .
[86] G. Amidon,et al. Effect of size and density on canine gastric emptying of nondigestible solids. , 1985, Gastroenterology.
[87] J. Meddings,et al. Review article: Intestinal permeability in Crohn's disease , 1997, Alimentary pharmacology & therapeutics.
[88] O. Corrigan. The biopharmaceutic drug classification and drugs administered in extended release (ER) formulations. , 1997, Advances in experimental medicine and biology.
[89] P. Sinko,et al. Site-specific oral absorption of didanosine: in situ characterization and correlation with extent of absorption in vivo , 1994 .
[90] R. Neubert,et al. Interactions between food components and drugs. Part 4: Influence of pectins and bile salts on propranolol absorption , 1996 .
[91] P. Watkins. Drug metabolism by cytochromes P450 in the liver and small bowel. , 1992, Gastroenterology clinics of North America.
[92] D. Rowbotham,et al. Cisapride. Drug interactions of clinical significance. , 1996, Drug safety.
[93] S. Piscitelli,et al. Protease inhibitors for the treatment of human immunodeficiency virus infection. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[94] R. Weintraub,et al. Drug Interactions with Grapefruit Juice , 1997, Clinical pharmacokinetics.
[95] P. Welling. THE EFFECTS OF FOOD ON DRUG ABSORPTION , 1996, Annual review of nutrition.
[96] F. Guengerich,et al. Role of cytochrome P450 enzymes in drug-drug interactions. , 1997, Advances in pharmacology.
[97] T. Browne,et al. Sensitivity Analysis of the Effect of Bioavailability or Dosage Form Content on Mean Steady State Phenytoin Concentration , 1991, Therapeutic Drug Monitoring.
[98] G. Amidon,et al. Physicochemical model for dose-dependent drug absorption. , 1984, Journal of pharmaceutical sciences.
[99] M. Härkönen,et al. Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls. , 1979, Scandinavian journal of gastroenterology.
[100] M. Rogge,et al. Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability , 1993, Journal of clinical pharmacology.
[101] R. Mäntylä,et al. Impairment of captopril bioavailability by concomitant food and antacid intake. , 1984, International journal of clinical pharmacology, therapy, and toxicology.
[102] K. Pittman,et al. Food‐induced reduction in bioavailability of didanosine , 1991, Clinical pharmacology and therapeutics.
[103] D. Fleisher,et al. Improved oral drug delivery: solubility limitations overcome by the use of prodrugs , 1996 .
[104] H. Blackburn. Olestra and the FDA. , 1996, The New England journal of medicine.
[105] N. Carulli,et al. Alcohol‐Drugs Interaction in Man: Alcohol and Tolbutamide * , 1971, European journal of clinical investigation.
[106] A. Dietz,et al. Ciprofloxacin Pharmacokinetics After a Standard or High‐Fat/High‐Calcium Breakfast , 1989, Journal of clinical pharmacology.
[107] D. Fleisher,et al. Colonic Absorption of Antiepileptic Agents , 1997, Epilepsia.
[108] W. Kirch,et al. Direct demonstration of small intestinal secretion and site‐dependent absorption of the β‐blocker talinolol in humans , 1996, Clinical pharmacology and therapeutics.
[109] D. Fleisher,et al. CCK antagonist pre-treatment inhibits meal-enhanced drug absorption in dogs , 1997, Regulatory Peptides.
[110] M. Horowitz,et al. Effects of increasing solid component size of a mixed solid/liquid meal on solid and liquid gastric emptying. , 1996, The American journal of physiology.
[111] J. Dressman,et al. Absorption of ACE inhibitors from small intestine and colon. , 1994, Journal of pharmaceutical sciences.
[112] J. M. Shaw,et al. Effect of Food on the Bioavailability of Captopril in Healthy Subjects , 1982, Journal of clinical pharmacology.
[113] J. Dressman,et al. Mixing-tank model for predicting dissolution rate control or oral absorption. , 1986, Journal of pharmaceutical sciences.
[114] C. Beglinger,et al. Relevance of p‐glycoprotein for the enteral absorption of cyclosporin A: in vitro‐in vivo correlation , 1996, British journal of pharmacology.
[115] B. Gidal,et al. Gabapentin Absorption: Effect of Mixing with Foods of Varying Macronutrient Composition , 1998, The Annals of pharmacotherapy.
[116] T. Nadai,et al. Effect of cyclodextrins on biological membrane. II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins. , 1992, Chemical & pharmaceutical bulletin.
[117] H. A. Koeleman,et al. The influence of different types of breakfast on the absorption of paracetamol among members of an ethnic group. , 1992, International journal of clinical pharmacology, therapy, and toxicology.
[118] Y. Seta,et al. Design and preparation of captopril sustained-release dosage forms and their biopharmaceutical properties , 1988 .
[119] S. Su,et al. Inhibition of the intestinal digoxin absorption and exsorption by quinidine. , 1996, Drug Metabolism And Disposition.
[120] Eric Woolf,et al. Single-Dose Pharmacokinetics of Indinavir and the Effect of Food , 1998, Antimicrobial Agents and Chemotherapy.
[121] J. N. Hunt. Does calcium mediate slowing of gastric emptying by fat in humans? , 1983, The American journal of physiology.
[122] G L Amidon,et al. The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids. , 1990, Gastroenterology.
[123] P. D. Chao,et al. Comparison of the Effects of Cimetidine and Ranitidine on the Pharmacokinetics of Disopyramide in Man , 1997, The Journal of pharmacy and pharmacology.
[124] D. Greenblatt,et al. Effect of Magnesium—Aluminum Hydroxide and Kaolin—Pectin on Absorption of Digoxin from Tablets and Capsules , 1981, Journal of clinical pharmacology.
[125] D. Fleisher,et al. Contrasting nutrient effects on the plasma levels of an amino acid-like antiepileptic agent from jejunal administration in dogs. , 1997, Journal of pharmaceutical sciences.
[126] G. Bailie,et al. Absorption Interactions With Fluoroquinolones , 1995, Drug safety.
[127] M. Cavet,et al. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco‐2) cells , 1996, British journal of pharmacology.
[128] U. Fuhr,et al. Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). , 1989, The American journal of medicine.